Published Date: 04 Mar 2023
Karnataka: Karnataka Examination Authority (KEA) yog PG AYUSH ...
Read Full NewsThird molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.
Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.
The World Health Organization on Thursday declared the hantavirus outbreak linked to a cruise ship over after the last identified contact of an exposed person completed...
New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said a migratory seabird found near a coastal town returned a positive...
The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.
New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.
A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.
1.
Long-Term CAR-T Results in Lymphoma Confirm Early Promise
2.
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says
3.
‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology
4.
Unified Neuro/Psych Residency Program: New Proposal.
5.
Millions of men could benefit from faster scan to diagnose prostate cancer
1.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
2.
Gene Therapy for Hemophilia: A New Hope on the Horizon
3.
Tumor Microenvironment Secretome Mapping in Cancer Biology
4.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
5.
Phosphate Vs. Phosphorus: What Is The Difference?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
5.
Current Scenario of Cancer- Q&A Session to Close the Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation